Dow Up 0.76% Nasdaq Up 0.69%

Dyax Corp. (DYAX)

-NGM
10.81 Up 0.07(0.65%) Oct 24, 3:59PM EDT
Prev Close:10.74
Open:10.73
Bid:7.01 x 100
Ask:N/A
1y Target Est:12.36
Beta:0.4
Next Earnings Date:28-Oct-14DYAX Earnings announcement
Day's Range:10.64 - 10.91
52wk Range:6.05 - 11.01
Volume:1,121,118
Avg Vol (3m):969,786
Market Cap:1.47B
P/E (ttm):N/A
EPS (ttm):-0.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXUp 0.65%1.47B
SHPGUp 5.14%38.02B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.19
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-3.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback